{
  "id": "mhgap#risk_safety_c65ac366",
  "content": "y There is limited information on the proportion of\nside-effects, in terms of raised transaminases and\nelectrographic seizures after resolution of clinical\nelevated ammonia levels. It is contraindicated in\nseizures in status epilepticus with different ASMs\nindividuals with liver disease, which may not be\nin children.\nevident when the person is brought in convulsing\ny As the outcome is highly dependent on the etiology\nand needs emergency treatment.\nof status epilepticus, trials in adults/children with\ny There is low-quality evidence that phenobarbital\nstatus epilepticus of specific etiology such as\nhas a higher risk of respiratory depression and\ninfectious etiology (e.g. encephalitis) may be useful.\ncardiovascular adverse effects as compared with\nsodium valproate. Implementation considerations\ny Phenobarbital and diazepam infusion carries y The choice of medicine is affected by a number of\nthe potential risk of sedation and respiratory factors, including availability, cost and side-effects.\ndepression, which may be increased if it is used y There are feasibility and affordability issues;\nafter benzodiazepines. intravenous fosphenytoin is not currently on the\ny Phenytoin has associated risks of arrhythmia and WHO EML (13).\nhypotension and can be difficult to administer in y Adults treated for established status epilepticus",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "medium",
    "topics": [
      "stress",
      "risk_safety",
      "management"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General â€” Risk Safety y There is limited information on the proportion of\nside-effects, in terms of raised transaminases and\nelectrographic seizures after resolution of clinical\nelevated ammonia levels. It is contraindicated in\nseizures in status epilepticus with different ASMs\nindividuals with liver disease, which may not be\nin children.\nevident when the person is brought in convulsing\ny As the outcome is highly dependent on the etiology\nand needs emergency treatment.\nof status epilepticus, trials in adults/children with\ny There is low-quality evidence that phenobarbital\nstatus epilepticus of specific etiology such as\nhas a higher risk of respiratory depression and\ninfectious etiology (e.g. encephalitis) may be useful.\ncardiovascular adverse effects as compared with\nsodium valproate. Implementation considerations\ny Phenobarbital and diazepam infusion carries y The choice of medicine is affected by a number of\nthe potential risk of sedation and respiratory factors, including availability, cost and side-effects.\ndepression, which may be increased if it is used y There are feasibility and affordability issues;\nafter benzodiazepines. intravenous fosphenytoin is not currently on the\ny Phenytoin has associated risks of arrhythmia and WHO EML (13).\nhypotension and can be difficult to administer in y Adults treated for established status epilepticus Y there is limited information on the proportion of\nside-effects, in terms of raised transaminases and\nelectrographic seizures after resolution of clinical\nelevated ammonia levels. it is contraindicated in\nseizures in st..."
}